Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Waters

Showing results (921-930 of 962) with videos related to

Pageof 97
Sort By:
Neurology(R) Neuroimmunology & Neuroinflammation|October 16, 2025
Plasma <i>N</i>-Glycan Profiling Enhances Diagnostic Precision in Multiple Sclerosis, AQP4-Ab NMOSD, and MOGADTereza Kacerova, Megan Sealey, Luisa Saldana, et al.
Journal of Pain and Symptom Management|December 2, 2008
Pain catastrophizing and pain-related fear in osteoarthritis patients: relationships to pain and disabilityTamara J Somers, Francis J Keefe, Jennifer J Pells, et al.
The Journal of Pathology|July 28, 2011
Using next-generation sequencing for the diagnosis of rare disorders: a family with retinitis pigmentosa and skeletal abnormalitiesKasmintan A Schrader, Alireza Heravi-Moussavi, Paula J Waters, et al.
Science (New York, N.Y.)|May 17, 2014
Mechanism of activation of protein kinase JAK2 by the growth hormone receptorAndrew J Brooks, Wei Dai, Megan L O'Mara, et al.
Science Advances|September 20, 2024
Exceptional hardness in multiprincipal element alloys via hierarchical oxygen heterogeneitiesDavid C Beaudry, Michael J Waters, Gianna M Valentino, et al.
ACS Medicinal Chemistry Letters|June 24, 2015
Aryl Pyrazoles as Potent Inhibitors of Arginine Methyltransferases: Identification of the First PRMT6 Tool CompoundLorna H Mitchell, Allison E Drew, Scott A Ribich, et al.
ACS Medicinal Chemistry Letters|March 18, 2016
Structure and Property Guided Design in the Identification of PRMT5 Tool Compound EPZ015666Kenneth W Duncan, Nathalie Rioux, P Ann Boriack-Sjodin, et al.
ACS Medicinal Chemistry Letters|May 26, 2015
EPZ011989, A Potent, Orally-Available EZH2 Inhibitor with Robust in Vivo ActivityJohn E Campbell, Kevin W Kuntz, Sarah K Knutson, et al.
Biopharmaceutics & Drug Disposition|January 14, 2014
Nonclinical pharmacokinetics and metabolism of EPZ-5676, a novel DOT1L histone methyltransferase inhibitorAravind Basavapathruni, Edward J Olhava, Scott R Daigle, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 2, 2013
Smg1 haploinsufficiency predisposes to tumor formation and inflammationTara L Roberts, Uda Ho, John Luff, et al.
Pageof 97

Showing results (921-930 of 962) with videos related to

Sort By:
Pageof 97
Neurology(R) Neuroimmunology & Neuroinflammation|October 16, 2025
Plasma <i>N</i>-Glycan Profiling Enhances Diagnostic Precision in Multiple Sclerosis, AQP4-Ab NMOSD, and MOGADTereza Kacerova, Megan Sealey, Luisa Saldana, et al.
Journal of Pain and Symptom Management|December 2, 2008
Pain catastrophizing and pain-related fear in osteoarthritis patients: relationships to pain and disabilityTamara J Somers, Francis J Keefe, Jennifer J Pells, et al.
The Journal of Pathology|July 28, 2011
Using next-generation sequencing for the diagnosis of rare disorders: a family with retinitis pigmentosa and skeletal abnormalitiesKasmintan A Schrader, Alireza Heravi-Moussavi, Paula J Waters, et al.
Science (New York, N.Y.)|May 17, 2014
Mechanism of activation of protein kinase JAK2 by the growth hormone receptorAndrew J Brooks, Wei Dai, Megan L O'Mara, et al.
Science Advances|September 20, 2024
Exceptional hardness in multiprincipal element alloys via hierarchical oxygen heterogeneitiesDavid C Beaudry, Michael J Waters, Gianna M Valentino, et al.
ACS Medicinal Chemistry Letters|June 24, 2015
Aryl Pyrazoles as Potent Inhibitors of Arginine Methyltransferases: Identification of the First PRMT6 Tool CompoundLorna H Mitchell, Allison E Drew, Scott A Ribich, et al.
ACS Medicinal Chemistry Letters|March 18, 2016
Structure and Property Guided Design in the Identification of PRMT5 Tool Compound EPZ015666Kenneth W Duncan, Nathalie Rioux, P Ann Boriack-Sjodin, et al.
ACS Medicinal Chemistry Letters|May 26, 2015
EPZ011989, A Potent, Orally-Available EZH2 Inhibitor with Robust in Vivo ActivityJohn E Campbell, Kevin W Kuntz, Sarah K Knutson, et al.
Biopharmaceutics & Drug Disposition|January 14, 2014
Nonclinical pharmacokinetics and metabolism of EPZ-5676, a novel DOT1L histone methyltransferase inhibitorAravind Basavapathruni, Edward J Olhava, Scott R Daigle, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 2, 2013
Smg1 haploinsufficiency predisposes to tumor formation and inflammationTara L Roberts, Uda Ho, John Luff, et al.
Pageof 97